tinidazole has been researched along with Gastritis in 38 studies
Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We attempted to investigate the role of clarithromycin with tinidazole on Helicobacter pylori-related gastritis from the aspects of clinical effect and COX-2 expression." | 8.02 | Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression. ( He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X, 2021) |
| "32 children (mean age 12 years, range 6-18) with non-specific abdominal pain and Campylobacter pylori positive gastritis received a six week course of daily oral amoxycillin (50 mg/kg) and tinidazole (20 mg/kg)." | 7.67 | Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. ( Ainley, C; Altare, F; Ansaldi, N; Holton, J; Oderda, G; Vaira, D, 1989) |
| " We attempted to investigate the role of clarithromycin with tinidazole on Helicobacter pylori-related gastritis from the aspects of clinical effect and COX-2 expression." | 4.02 | Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression. ( He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X, 2021) |
| " pylori strain (34 duodenal ulcer and 37 nonulcer dyspepsia) received omeprazole 40 mg o." | 3.70 | Weekend therapy for the treatment of Helicobacter pylori infection. ( Agosti, R; Bocus, P; Caletti, G; Grigioni, WF; Mazzoni, C; Orcioni, GF; Paparo, GF; Poli, L; Sottili, S; Togliani, T; Tucci, A, 1998) |
| " pylori-infected patients with duodenal ulcer were treated with either omeprazole or famotidine plus two antibiotics for 2 wk." | 3.70 | The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. ( Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M, 2000) |
| "32 children (mean age 12 years, range 6-18) with non-specific abdominal pain and Campylobacter pylori positive gastritis received a six week course of daily oral amoxycillin (50 mg/kg) and tinidazole (20 mg/kg)." | 3.67 | Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. ( Ainley, C; Altare, F; Ansaldi, N; Holton, J; Oderda, G; Vaira, D, 1989) |
| "The most common adverse event was the dysgeusia in both the groups." | 2.87 | Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial. ( Shahbazi, S; Vahdat Shariatpanahi, Z, 2018) |
| " Twenty-four patients experienced side-effects, but in only seven cases was treatment discontinued due to adverse events." | 2.69 | Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate. ( Bazzoli, F; Cannizzaro, O; D'Angelo, A; Ederle, A; Fossi, S; Gerace, G; Iaquinto, G; Olivieri, A; Pozzato, P; Reina, G; Ricciardiello, L; Roda, E; Scarpulla, G; Spadaccini, A; Tosatto, R; Zagari, M, 1998) |
| "pylori-positive GERD patients randomly assigned to either an eradication or omeprazole-alone regime." | 2.69 | Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. ( Axon, AT; Bardhan, K; Dixon, MF; Moayyedi, P; Peacock, R; Walan, A; Wason, C, 2000) |
| " Although the dosage of omeprazole in pediatric patients has not been established (no pediatric formulation exists), clarithromycin is available for use in pediatric patients." | 2.40 | Guidelines for the treatment of Helicobacter pylori in the pediatric population. ( Abdel-Rahman, SM; Nahata, MC; Robinson, DM, 1997) |
| "pylori gastritis is equally prevalent in symptomatic and asymptomatic children (31 and 27." | 1.29 | Helicobacter pylori-associated gastritis in Kuwait: endoscopy-based study in symptomatic and asymptomatic children. ( al Nakib, B; Kalaoui, M; Patric, J; Radhakrishnan, S, 1993) |
| "pylori was detected in dental plaque and in gastric antral and body mucosa in 98%, 67% and 70%, respectively, of 43 consecutive patients with dyspepsia." | 1.28 | Dental plaque: a permanent reservoir of Helicobacter pylori? ( Desai, HG; Gill, HH; Mehta, PR; Prabhu, SR; Shankaran, K, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (10.53) | 18.7374 |
| 1990's | 20 (52.63) | 18.2507 |
| 2000's | 7 (18.42) | 29.6817 |
| 2010's | 5 (13.16) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| He, C | 1 |
| Kong, F | 2 |
| Zhu, X | 1 |
| Zhao, W | 1 |
| Liu, Y | 1 |
| Wang, K | 1 |
| Myint, NPST | 1 |
| Zaw, TT | 1 |
| Sain, K | 1 |
| Waiyan, S | 1 |
| Danta, M | 1 |
| Cooper, D | 1 |
| Aung, NM | 1 |
| Kyi, MM | 1 |
| Hanson, J | 1 |
| Manfredi, M | 1 |
| Gaiani, F | 1 |
| Kayali, S | 1 |
| Bizzarri, B | 1 |
| Iuliano, S | 1 |
| Minelli, R | 1 |
| Leandro, G | 1 |
| Di Mario, F | 1 |
| De' Angelis, GL | 1 |
| Shahbazi, S | 1 |
| Vahdat Shariatpanahi, Z | 1 |
| Gong, EJ | 1 |
| Yun, SC | 1 |
| Jung, HY | 1 |
| Lim, H | 1 |
| Choi, KS | 1 |
| Ahn, JY | 1 |
| Lee, JH | 1 |
| Kim, DH | 1 |
| Choi, KD | 1 |
| Song, HJ | 1 |
| Lee, GH | 1 |
| Kim, JH | 1 |
| Metanat, HA | 1 |
| Valizadeh, SM | 1 |
| Fakheri, H | 1 |
| Maleki, I | 1 |
| Taghvaei, T | 1 |
| Hosseini, V | 1 |
| Bari, Z | 1 |
| Choi, HS | 1 |
| Chun, HJ | 1 |
| Park, SH | 1 |
| Keum, B | 1 |
| Seo, YS | 1 |
| Kim, YS | 1 |
| Jeen, YT | 1 |
| Um, SH | 1 |
| Lee, HS | 1 |
| Kim, CD | 1 |
| Ryu, HS | 1 |
| Oderda, G | 3 |
| Marinello, D | 1 |
| Lerro, P | 1 |
| Kuvidi, M | 1 |
| de'Angelis, GL | 1 |
| Ferzetti, A | 1 |
| Cucchiara, S | 1 |
| Franco, MT | 1 |
| Romano, C | 1 |
| Strisciuglio, P | 1 |
| Pensabene, L | 1 |
| Francavilla, R | 1 |
| Lionetti, E | 1 |
| Castellaneta, SP | 1 |
| Magistà, AM | 1 |
| Boscarelli, G | 1 |
| Piscitelli, D | 1 |
| Amoruso, A | 1 |
| Di Leo, A | 1 |
| Miniello, VL | 1 |
| Francavilla, A | 1 |
| Cavallo, L | 1 |
| Ierardi, E | 1 |
| Ziemniak, W | 1 |
| Chen, MJ | 1 |
| Shih, SC | 1 |
| Wang, TE | 1 |
| Chan, YJ | 1 |
| Chen, CJ | 1 |
| Chang, WH | 1 |
| Choné, L | 1 |
| Fléjou, JF | 1 |
| Grignon, Y | 1 |
| Bigard, MA | 1 |
| Ashorn, M | 1 |
| Ruuska, T | 1 |
| Karikoski, R | 1 |
| Miettinen, A | 1 |
| Mäki, M | 1 |
| Bruel, H | 1 |
| Dabadie, A | 1 |
| Pouedras, P | 1 |
| Gambert, C | 1 |
| Le Gall, E | 1 |
| Jezequel, C | 1 |
| Radhakrishnan, S | 1 |
| al Nakib, B | 1 |
| Kalaoui, M | 1 |
| Patric, J | 1 |
| Bazzoli, F | 2 |
| Moshkowitz, M | 2 |
| Konikoff, FM | 1 |
| Peled, Y | 1 |
| Brill, S | 2 |
| Hallak, A | 1 |
| Tiomny, E | 1 |
| Santo, M | 1 |
| Bujanover, Y | 2 |
| Gilat, T | 1 |
| Drake, IM | 1 |
| Axon, TT | 1 |
| Clarke, AH | 1 |
| Delpre, G | 1 |
| Livni, E | 1 |
| Niv, Y | 1 |
| Robinson, DM | 1 |
| Abdel-Rahman, SM | 1 |
| Nahata, MC | 1 |
| Mégraud, F | 1 |
| Malfertheiner, P | 1 |
| Ponzetto, A | 1 |
| Boero, M | 2 |
| Bellis, D | 2 |
| Forni, M | 1 |
| Vaira, D | 2 |
| Ansaldi, N | 2 |
| Tucci, A | 1 |
| Poli, L | 1 |
| Paparo, GF | 1 |
| Bocus, P | 1 |
| Togliani, T | 1 |
| Mazzoni, C | 1 |
| Orcioni, GF | 1 |
| Agosti, R | 1 |
| Grigioni, WF | 1 |
| Sottili, S | 1 |
| Caletti, G | 1 |
| Parente, F | 1 |
| Imbesi, V | 1 |
| Maconi, G | 1 |
| Cucino, C | 1 |
| Manzionna, G | 1 |
| Vago, L | 1 |
| Bianchi Porro, G | 1 |
| Reif, S | 1 |
| Ringel, Y | 1 |
| Arber, N | 1 |
| Halpern, Z | 1 |
| Ricciardiello, L | 1 |
| Cannizzaro, O | 1 |
| D'Angelo, A | 1 |
| Ederle, A | 1 |
| Gerace, G | 1 |
| Iaquinto, G | 1 |
| Reina, G | 1 |
| Scarpulla, G | 1 |
| Spadaccini, A | 1 |
| Olivieri, A | 1 |
| Tosatto, R | 1 |
| Fossi, S | 1 |
| Pozzato, P | 1 |
| Zagari, M | 1 |
| Roda, E | 1 |
| Rollan, A | 1 |
| Giancaspero, R | 1 |
| Fuster, F | 1 |
| Acevedo, C | 1 |
| Figueroa, C | 1 |
| Hola, K | 1 |
| Schulz, M | 1 |
| Duarte, I | 1 |
| Moayyedi, P | 1 |
| Wason, C | 1 |
| Peacock, R | 1 |
| Walan, A | 1 |
| Bardhan, K | 1 |
| Axon, AT | 1 |
| Dixon, MF | 1 |
| Rathi, P | 1 |
| Sawant, P | 1 |
| Gopanpallikar, A | 1 |
| Di Napoli, A | 1 |
| Petrino, R | 1 |
| Chiandussi, L | 1 |
| Adeyemi, EO | 1 |
| Fadlalla, H | 1 |
| al-Homsi, M | 1 |
| Nnalue, NA | 1 |
| Goodwin, S | 1 |
| Boehme, D | 1 |
| Sim, AJ | 1 |
| Desai, HG | 2 |
| Gill, HH | 2 |
| Shankaran, K | 1 |
| Mehta, PR | 2 |
| Prabhu, SR | 2 |
| Ranganathan, S | 1 |
| Kalro, RH | 1 |
| Murti, PK | 1 |
| Iserhard, R | 1 |
| Freise, J | 1 |
| Wagner, S | 1 |
| Bokemeyer, B | 1 |
| Weissbrodt, H | 1 |
| Fritsch, RS | 1 |
| Soudah, B | 1 |
| Schmidt, FW | 1 |
| Holton, J | 1 |
| Ainley, C | 1 |
| Altare, F | 1 |
| Borody, TJ | 1 |
| Carrick, J | 1 |
| Hazell, SL | 1 |
| Kasper, G | 1 |
| Dickgiesser, N | 1 |
| Marshall, BJ | 1 |
| Armstrong, JA | 1 |
| McGechie, DB | 1 |
| Glancy, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection[NCT02711176] | Phase 4 | 212 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
| Phase 4, Prospective, Randomized and Comparative Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice[NCT01273441] | Phase 4 | 338 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
| Sequential Versus Concomitant Therapy for Helicobacter Pylori Infection[NCT00656968] | Phase 4 | 232 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT00656968)
Timeframe: one month after finishing study drugs
| Intervention | participants (Number) |
|---|---|
| Concomitant Therapy (A) | 92 |
| Sequential Therapy (B) | 95 |
Good drug compliance is defined as taking equal to or more than 80% of eradication medicines (NCT00656968)
Timeframe: one month after finishing test therapy
| Intervention | participants (Number) |
|---|---|
| Concomitant Therapy (A) | 106 |
| Sequential Therapy (B) | 104 |
2 reviews available for tinidazole and Gastritis
| Article | Year |
|---|---|
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Communicab | 2014 |
Guidelines for the treatment of Helicobacter pylori in the pediatric population.
Topics: Adolescent; Amoxicillin; Bismuth; Child; Child, Preschool; Drug Therapy, Combination; Duodenal Ulcer | 1997 |
16 trials available for tinidazole and Gastritis
| Article | Year |
|---|---|
Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability.
Topics: Amoxicillin; Clarithromycin; Drug Costs; Drug Therapy, Combination; Gastritis; Helicobacter Infectio | 2020 |
Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial.
Topics: Adult; Amoxicillin; Clarithromycin; Dysgeusia; Esomeprazole; Female; Gastritis; Helicobacter Infecti | 2018 |
Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; | 2015 |
Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti | 2012 |
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Breath Tests; Child; Double-Blind | 2004 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 2006 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Admin | 1996 |
Ranitidine in a twice daily triple-therapy regimen for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Com | 1996 |
Family treatment of symptomatic children with Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Carrier State; Child; Child, Preschool; Chronic Disease; Disease Tra | 1997 |
Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsi | 1998 |
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Administrat | 1998 |
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; B | 1998 |
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Dr | 2000 |
Comparison of two regimens on eradication of Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Th | 2000 |
Mono and dual therapy for Helicobacter pylori associated gastritis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; G | 1991 |
20 other studies available for tinidazole and Gastritis
| Article | Year |
|---|---|
Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combinati | 2021 |
How and when investigating and treating Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance | 2018 |
Endoscopic patterns and histopathological features after eradication therapy in Helicobacter pylori-associated nodular gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alkylating Agents; Amoxicillin; Anti-Bacterial Agent | 2008 |
[Helicobacter heilmannii: new spiral shaped bacterium that may be responsible for ulcerated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Ulcer Agents; Drug Therapy | 1995 |
Helicobacter pylori gastritis in dyspeptic children. A long-term follow-up after treatment with colloidal bismuth subcitrate and tinidazole.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; Drug Therapy, Combination; Dyspepsia; Female; Follo | 1994 |
[Helicobacter pylori gastritis manifested by acute anemia].
Topics: Acute Disease; Amoxicillin; Anemia; Antibodies, Bacterial; Child; Drug Therapy, Combination; Endosco | 1993 |
Helicobacter pylori-associated gastritis in Kuwait: endoscopy-based study in symptomatic and asymptomatic children.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Amoxicillin; Biopsy; Child; Child, Preschool; Duod | 1993 |
Italian omeprazole triple therapy--a 1-week regimen.
Topics: Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter | 1996 |
Urticaria during triple therapy for Helicobacter pylori infection: clinical implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Eruptions; Drug Therapy, Combination; Fe | 1997 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resist | 1996 |
Weekend therapy for the treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Sc | 1998 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, | 2000 |
Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Chronic Disease; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gastros | 1992 |
Clinicopathological assessment of gastric biopsy samples of patients with Helicobacter pylori infection--metronidazole resistance and compliance problems in the United Arab Emirates.
Topics: Adolescent; Adult; Antacids; Bacteriological Techniques; Bismuth; Doxycycline; Drug Resistance, Micr | 1992 |
Dental plaque: a permanent reservoir of Helicobacter pylori?
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Dental Plaque; Doxycycline; Drug Therapy, Combinatio | 1991 |
Epidemiology and treatment of gastric Campylobacter pylori infection: more questions than answers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Diagnosis, Differential; Drug Ther | 1990 |
Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels.
Topics: Administration, Oral; Adolescent; Amoxicillin; Antibodies, Bacterial; Campylobacter; Campylobacter I | 1989 |
Symptoms improve after the eradication of gastric Campylobacter pyloridis.
Topics: Adult; Aged; Amoxicillin; Campylobacter Infections; Drug Therapy, Combination; Female; Gastritis; Hu | 1987 |
[Clinical significance, epidemiology and laboratory diagnosis of Campylobacter pyloridis].
Topics: Amoxicillin; Antibodies, Bacterial; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Chroni | 1986 |
Attempt to fulfil Koch's postulates for pyloric Campylobacter.
Topics: Achlorhydria; Acute Disease; Adult; Biopsy; Campylobacter; Campylobacter Infections; Chronic Disease | 1985 |